The Better Business Bureau's advertising watchdog has escalated its review of prediction market platform Kalshi after the company declined to participate in an inquiry over how it handles influencer disclosures. The move signals a deepening regulatory concern about transparency in digital promotions.
Why the inquiry was opened
The watchdog, which polices advertising standards, opened a review of Kalshi's influencer disclosure practices. The aim was to determine whether the platform properly flagged paid endorsements and sponsored content from influencers who promote its prediction markets. Such disclosures are required under industry guidelines to prevent deceptive marketing.
The exact details of the complaint that triggered the inquiry have not been made public. But the watchdog typically acts on consumer complaints or competitor challenges. In recent years, social media influencers have come under increased scrutiny for failing to clearly label paid partnerships.
Kalshi's decision to decline
Kalshi chose not to take part in the voluntary review process. That refusal is what prompted the watchdog to escalate the matter. Under standard procedures, when a company opts out, the review moves from a cooperative phase to a formal investigation.
The company's decision leaves the watchdog with fewer options for resolving the issue through industry self-regulation. Escalation often means the case gets referred to a government regulator that can compel compliance. But the watchdog has not said which agency — if any — will take the next step.
What happens next
For now, the process is in the watchdog's hands. The escalation itself does not carry legal penalties, but it opens the door to further action. If a referral is made, Kalshi could face a formal probe by a federal or state authority.
The case highlights the tension between fast-growing prediction market platforms and the slower-moving rules that govern advertising. Kalshi, which lets users bet on the outcome of events, has built a sizable user base. But its marketing practices are now under a spotlight it cannot easily ignore.
The watchdog has not announced a timeline for the next stage of the review. Whether Kalshi will eventually cooperate or face a regulatory referral remains an open question.
